Prostate-specific antigen decline after withdrawal of low-dose megestrol acetate [2]

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 1087-1088

  Burch, P A ^a   Loprinzi, C L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTAMIDE; MEGESTROL ACETATE; PROSTATE SPECIFIC ANTIGEN;

ADULT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; DRUG WITHDRAWAL; HOT FLUSH; HUMAN; LETTER; MALE; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RISK;

ANTINEOPLASTIC AGENTS, HORMONAL; COMBINED MODALITY THERAPY; FLUTAMIDE; HUMANS; MALE; MEGESTROL ACETATE; MIDDLE AGED; ORCHIECTOMY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0033015294     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)